"use client";

import Image from "next/image";
import { useEffect, useRef } from "react";
import chinaSvg from "../public/images/China.svg";
import usaSvg from "../public/images/US.svg";
import womanInOffice from "../public/images/woman-in-office.jpg";

export default function Parallax() {
  const usaSvgRef = useRef<HTMLImageElement>(null);
  const chinaSvgRef = useRef<HTMLImageElement>(null);

  useEffect(() => {
    const handleScroll = () => {
      const scrollY = window.scrollY;
      const isSmallScreen = window.innerWidth < 1024;

      if (usaSvgRef.current) {
        const scale = isSmallScreen
          ? Math.min(1 + scrollY / 2000, 1.1)
          : Math.min(1 + scrollY / 800, 2);
        const translateY = isSmallScreen
          ? Math.min(scrollY / 4, 100)
          : Math.min(scrollY / 2, 300);
        usaSvgRef.current.style.transform = `translateY(${translateY}px) scale(${scale})`;
      }

      if (chinaSvgRef.current) {
        const scale = isSmallScreen
          ? Math.min(1 + (scrollY - 800) / 2000, 1.1)
          : Math.min(1 + (scrollY - 800) / 800, 2);
        const translateY = isSmallScreen
          ? Math.min((scrollY - 800) / 4, 100)
          : Math.min((scrollY - 800) / 2, 300);
        chinaSvgRef.current.style.transform = `translateY(${translateY}px) scale(${scale})`;
      }
    };

    window.addEventListener("scroll", handleScroll);
    return () => window.removeEventListener("scroll", handleScroll);
  }, []);

  return (
    <div className="relative bg-black text-white min-h-screen">
      {/* Sticky Background Image */}
      <div className="sticky top-0 h-screen">
        <div className="relative h-full">
          <Image
            src={womanInOffice}
            alt="Woman in Office"
            layout="fill"
            objectFit="cover"
            objectPosition="bottom left"
            priority
          />
        </div>
      </div>

      {/* Parallax Content */}
      <div className="relative z-10 mx-auto max-w-7xl px-6 lg:px-8 space-y-32 pb-32">
        {/* Heading Section */}
        <div className="text-center py-12">
          <h1 className="text-5xl font-medium tracking-tight sm:text-6xl lg:text-7xl leading-tight">
            Areas We Serve
          </h1>
        </div>

        {/* USA Section */}
        <section className="parallax-section py-24 sm:py-32 lg:px-8">
          <div className="grid grid-cols-1 lg:grid-cols-2 gap-8 items-start">
            <div className="flex justify-center lg:justify-start relative">
              <div className="usa-svg-container">
                <Image
                  src={usaSvg}
                  alt="United States"
                  width={300}
                  height={180}
                  className="object-contain usa-image"
                  ref={usaSvgRef}
                />
              </div>
            </div>
            <div className="usa-text-container flex flex-col justify-center mt-8 lg:mt-0 lg:pl-10">
              <h2 className="text-4xl font-medium tracking-tight sm:text-5xl lg:text-6xl leading-tight">
                United States
              </h2>
              <p className="mt-8 text-lg leading-8">
                As a regulatory services platform, we specialize in facilitating
                New Drug Application (NDA) filings and Abbreviated New Drug
                Application (ANDA) filings with the U.S. Food and Drug
                Administration (FDA). We ensure that pharmaceutical companies
                can quickly and efficiently submit their applications for new
                drugs or generic versions of existing drugs. For NDAs, we
                meticulously compile comprehensive information on safety,
                efficacy, labeling, manufacturing processes, and quality
                controls. When it comes to ANDAs, we focus on demonstrating
                bioequivalence to reference drugs through rigorous evaluations.
                Our goal is to support the continuous evaluation and improvement
                of the pharmaceutical landscape, making safe and effective
                medications accessible to patients across the United States.
              </p>
            </div>
          </div>
        </section>

        {/* China Section */}
        <section className="parallax-section py-24 sm:py-32 lg:px-8">
          <div className="grid grid-cols-1 lg:grid-cols-2 gap-8 items-start">
            <div className="flex justify-center lg:justify-start relative">
              <div className="china-svg-container">
                <Image
                  src={chinaSvg}
                  alt="China"
                  width={300}
                  height={180}
                  className="object-contain china-image"
                  ref={chinaSvgRef}
                />
              </div>
            </div>
            <div className="china-text-container flex flex-col justify-center mt-8 lg:mt-0 lg:pl-10">
              <h2 className="text-4xl font-medium tracking-tight sm:text-5xl lg:text-6xl leading-tight">
                China
              </h2>
              <p className="mt-8 text-lg leading-8">
                For the Chinese market, we specialize in facilitating New Drug
                Applications (NDAs). Our expertise ensures that pharmaceutical
                companies can efficiently submit their applications for new
                chemical drugs, new biological products, gene and cell
                therapies, new vaccines, and new traditional Chinese medicines
                approved for the first time in mainland China. Notably, the
                National Medical Products Administration (NMPA) in China set a
                new record in 2023 by approving the highest number of new drugs
                in a single yearâ€”104 in total. These approvals encompassed a
                wide range of therapeutic areas, including oncology drugs,
                anti-infective drugs, and central nervous system (CNS) drugs.
                Additionally, our platform supports the expedited regulatory
                pathways for rare disease drugs and pediatric drugs, addressing
                unmet clinical needs and ensuring that innovative treatments
                reach patients efficiently.
              </p>
            </div>
          </div>
        </section>
      </div>

      {/* Custom CSS for Parallax Effect */}
      <style jsx>{`
        .usa-svg-container,
        .china-svg-container {
          position: absolute;
          top: -200px;
          left: 50%;
          transform: translateX(-50%);
        }
        .china-svg-container {
          top: -200px;
        }
        .usa-image,
        .china-image {
          transition: transform 0.1s ease-out;
        }
        @media (max-width: 1024px) {
          .usa-svg-container,
          .china-svg-container {
            position: relative;
            top: 0;
            left: 0;
            transform: none;
            margin-bottom: 80px; /* Increase margin to separate SVG and text on small screens */
          }
          .usa-text-container,
          .china-text-container {
            text-align: center;
            padding-left: 0;
          }
          .usa-image,
          .china-image {
            width: 200px; /* Smaller width for SVGs on smaller screens */
            height: auto;
          }
        }
      `}</style>
    </div>
  );
}
